Loading...
XJSEACT
Market cap99mUSD
Dec 23, Last price  
224.00ZAR
1D
6.67%
1Q
-25.08%
Jan 2017
-63.22%
IPO
-44.00%
Name

Afrocentric Investment Corporation Ltd

Chart & Performance

D1W1MN
XJSE:ACT chart
P/E
3,329.01
P/S
20.74
EPS
0.07
Div Yield, %
0.06%
Shrs. gr., 5y
8.02%
Rev. gr., 5y
10.91%
Revenues
8.89b
+0.26%
00519,867,0001,263,414,0001,351,254,0001,448,261,0001,770,330,0001,958,260,0002,098,312,0003,148,146,0003,784,701,0004,212,705,0005,296,792,0006,440,966,0008,074,418,0008,722,570,0008,868,032,0008,890,706,000
Net income
55m
-69.82%
4,673,00010,810,00034,701,000-7,413,000117,248,000164,506,000184,109,000170,661,000154,032,000165,251,000117,669,000256,611,000269,880,000303,575,000302,033,000312,804,000183,523,00055,381,000
CFO
814m
+113.38%
-802,000-8,112,00047,222,000115,834,000103,993,000116,236,000227,080,000141,941,000177,395,000191,733,000205,188,000290,519,000306,767,000501,708,000385,264,000527,018,000381,694,000814,469,000
Dividend
May 08, 202411 ZAR/sh
Earnings
Mar 10, 2025

Profile

AfroCentric Investment Corporation Limited, an investment holding company, provides health administration and health risk management solutions to the healthcare sector. The company operates through Healthcare SA, Healthcare Retail, Healthcare Africa, and Information Technology segments. It offers documentation based care equipment and administration services to 12 musculoskeletal treatment centers; and engages in the retail and wholesale of pharmaceutical products under the Pharmacy Direct, MMed, Scriptpharm Risk Management, Curasana Wholesaler, and Activo Health names. The company also provides HIV and other healthcare management solutions. It operates in South Africa, Botswana, Mauritius, Namibia, Eswatini, and Zimbabwe. AfroCentric Investment Corporation Limited was incorporated in 2008 and is based in Roodepoort, South Africa.
URL
http://www.afrocentric.za.com/
IPO date
May 17, 2006
Employees
Domiciled in
ZA
Incorporated in
ZA

Valuation

Title
ZAR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
8,890,706
0.26%
8,868,032
1.67%
8,722,570
8.03%
Cost of revenue
5,883,867
4,694,526
2,614,600
Unusual Expense (Income)
NOPBT
3,006,839
4,173,506
6,107,970
NOPBT Margin
33.82%
47.06%
70.02%
Operating Taxes
132,729
131,654
193,453
Tax Rate
4.41%
3.15%
3.17%
NOPAT
2,874,110
4,041,852
5,914,517
Net income
55,381
-69.82%
183,523
-41.33%
312,804
3.57%
Dividends
(119,101)
(163,828)
(293,917)
Dividend yield
4.99%
6.48%
11.28%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
123,889
291,651
190,960
Long-term debt
858,689
949,015
855,272
Deferred revenue
Other long-term liabilities
1,680
18,795
94,684
Net debt
652,319
893,764
798,567
Cash flow
Cash from operating activities
814,469
381,694
527,018
CAPEX
(73,909)
(258,420)
(303,690)
Cash from investing activities
(382,766)
(287,484)
(382,972)
Cash from financing activities
(179,349)
(151,950)
(208,266)
FCF
3,028,612
4,729,048
5,354,118
Balance
Cash
330,259
189,763
138,589
Long term investments
157,139
109,076
Excess cash
Stockholders' equity
864,936
4,379,413
2,353,333
Invested Capital
4,208,357
4,504,970
4,371,240
ROIC
65.97%
91.07%
137.39%
ROCE
67.30%
88.27%
132.39%
EV
Common stock shares outstanding
837,398
609,537
593,729
Price
2.85
-31.33%
4.15
-5.47%
4.39
-0.68%
Market cap
2,386,585
-5.65%
2,529,577
-2.95%
2,606,469
-0.10%
EV
3,070,093
6,884,362
4,402,527
EBITDA
3,346,418
4,530,685
6,489,825
EV/EBITDA
0.92
1.52
0.68
Interest
96,235
81,091
65,686
Interest/NOPBT
3.20%
1.94%
1.08%